Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Source: Eur Respir J 2008; 31: 908-909 Year: 2008
Effectiveness of itraconazole and systemic steroids in the treatment of ABPA Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 301s Year: 2007
Use of amphotericin B lipid complex in aspergillus infections of the lung: efficacy and safety Source: Eur Respir J 2001; 18: Suppl. 33, 304s Year: 2001
Weekly nebulisation of liposomal amphotericin B for the treatment of endobronchial aspergillus fumigatus infection in cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 213s Year: 2004
Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010
An open label randomized controlled trial comparing nebulized amphotericin B with oral itraconazole in patients with pulmonary aspergilloma Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020
Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001
Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
A placebo-controlled study of liposomal amikacin for inhalation nebulized once daily in the treatment of bronchiectasis patients with chronic pseudomonas aeruginosa lung infection Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
Efficacy of 12-month treatment with inhaled corticosteroid in bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003
Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001
Add on therapy of pure theophylline sollution with systemic corticosteroid is more effective for the treatment of asthma attack Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies Source: Eur Respir J, 56 (4) 2000110; 10.1183/13993003.00110-2020 Year: 2020
Hydrofluoroalkane beclomethasone dipropionate extra fine aerosol efficacy response at reduced dose compared to other inhaled corticosteroid treatment regimens Source: Eur Respir J 2001; 18: Suppl. 33, 70s Year: 2001
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Source: Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 Year: 2021
Efficacy of a combination therapy with single inhaler budesonide/formoterol in the treatment of acute exacerbations of COPD (AECOPD) Source: Eur Respir J 2004; 24: Suppl. 48, 252s Year: 2004